首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to infl
【24h】

Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to infl

机译:Orazipone抑制炎症转录因子核因子-κB和信号转导和转录激活因子1的活化,并降低可诱导的一氧化氮合酶表达和一氧化氮的产生

获取原文
获取原文并翻译 | 示例
           

摘要

Orazipone [OR-1384; 3-[4-(methylsulfonyl)benzylidene]pentane-2,4-dione] is a novel sulfhydryl-modulating compound that has anti-inflammatory properties in experimental models of asthma and inflammatory bowel disease. In inflammation, inducible nitricoxide synthase (iNOS) generates NO, which modulates the immune response. Compounds that inhibit iNOS expression or iNOS activity possess anti-inflammatory effects. In the present study, we examined the effects of orazipone and its derivative OR-1958 [3-[3-chlorine-4-(methylsulfonyl)benzylidene]pentane-2,4-dione] on iNOS expression and NO production in J774 macrophages stimulated by bacterial lipopolysaccharide (LPS) and in human alveolar epithelial cells activated by proinflammatory cytokines. Protein expression and nuclear translocation of transcription factors were measured by Western blot. iNOS mRNA expression was determined by quantitative reverse transcription-polymerase chain reaction and iNOS mRNA stability by actinomycin D assay. iNOS promoter activity was studied in a cell line expressing luciferase under the control of iNOS promoter. Orazipone and its derivative OR-1958 but not its nonthiol-modulating analog inhibited iNOS expression and NO production in a concentration-dependent manner. Orazipone decreased LPS-induced iNOS mRNA expression, but the decay of iNOS mRNA was not affected. Orazipone extensively prevented LPS-induced activation of nuclear factor kappaB (NF-kappaB) and signal transducer and activator of transcription (STAT) 1, which are important transcription factors for iNOS. In agreement, human iNOS promoter activity was inhibited by orazipone. In conclusion, orazipone decreased activation of inflammatory transcription factors NF-kappaB and STAT1, and expression of iNOS in cells exposed to inflammatory stimuli. The thiolmodulating property seems to be critical in mediating the antiinflammatory effects of orazipone.
机译:Orazipone [OR-1384; 3- [4-(甲基磺酰基)亚苄基]戊烷-2,4-二酮]是一种新型的巯基调节化合物,在哮喘和炎症性肠病的实验模型中具有抗炎特性。在炎症中,诱导型一氧化氮合酶(iNOS)产生NO,从而调节免疫反应。抑制iNOS表达或iNOS活性的化合物具有抗炎作用。在本研究中,我们检查了orazipone及其衍生物OR-1958 [3- [3-氯-4-(甲基磺酰基)亚苄基]戊烷-2,4-二酮]对刺激的J774巨噬细胞中iNOS表达和NO产生的影响。通过细菌脂多糖(LPS)和在人肺泡上皮细胞中被促炎性细胞因子激活。通过蛋白质印迹法测量蛋白质表达和转录因子的核易位。通过定量逆转录-聚合酶链反应确定iNOS mRNA的表达,并通过放线菌素D测定法确定iNOS mRNA的稳定性。在表达荧光素酶的细胞系中,在iNOS启动子的控制下研究了iNOS启动子的活性。 Orazipone及其衍生物OR-1958而不是其非硫醇调节类似物以浓度依赖性方式抑制iNOS表达和NO产生。 Orazipone降低LPS诱导的iNOS mRNA表达,但不影响iNOS mRNA的衰减。 Orazipone广泛阻止LPS诱导的核因子kappaB(NF-kappaB)以及信号转导和转录激活剂(STAT)1的激活,这是iNOS的重要转录因子。一致的是,人iNOS启动子活性被orazipone抑制。总之,奥拉西酮降低了炎性转录因子NF-κB和STAT1的活化,以及iNOS在暴露于炎性刺激的细胞中的表达。硫醇调节性质似乎在介导奥拉西酮的抗炎作用中至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号